+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Oligonucleotide Synthesis Market to 2027 - Regional Analysis and Forecasts by Product, Application, End User, and Country

  • PDF Icon

    Report

  • 159 Pages
  • October 2019
  • Region: Asia Pacific
  • The Insight Partners
  • ID: 4858438
The Asia Pacific oligonucleotide synthesis market is expected to reach US$ 872.98 Mn in 2027 from US$ 334.26 Mn in 2018. The market is estimated to grow with a CAGR of 14.7% from 2019-2027.

The growth of the oligonucleotide synthesis market is primarily attributed to the growing use of synthesized oligonucleotides and government support for biotechnology research in Asia Pacific. However, dearth of skilled professional is likely to pose a negative impact on the market growth.

The rising awareness about wide range of applications of oligonucleotide synthesis has led government to fund research activities. Department of Biotechnology (DBT), New Delhi and Council of Scientific and Industrial Research (CSIR), New Delhi are working towards funding activities related to oligonucleotide synthesis. Oligonucleotides has tremendous potential application in treating wide range of medical conditions. They enable the development of therapeutics as the malfunctioning genes can be targeted, manipulated, silenced and/or modulated. In 2017, GeneDesign, Inc. established a new production facility for development of oligonucleotide drug substance in Osaka, Japan.

In 2018, the synthesized oligonucleotides segment held the most significant market share of the oligonucleotide synthesis market, by product. This segment is also anticipated to dominate the market in 2027 owing to increasing use of the product in research and diagnostic purposes. Also, the segment is anticipated to witness growth at a significant rate during the forecast period, 2018 to 2027.

In 2018, the research segment held a most significant market share of the oligonucleotide synthesis market, by application. This segment is also estimated to dominate the market in 2027 owing to the availability of funds as well as supportive government policies. Also, the segment is also anticipated to witness growth at a significant rate during the forecast period, 2018 to 2027.

In 2018, the academic research institutes segment held the most significant market share of the oligonucleotide synthesis market, by end user. This segment is also projected to dominate the market in 2027 due to rise in government funding for research institutes. However, the diagnostic laboratories segment is anticipated to witness growth at a significant rate during the forecast period, 2018 to 2027, due to the efficiency of oligonucleotides for diagnostic process.

Some of the major primary and secondary sources for oligonucleotide synthesis included in the report are, Department Of Biotechnology, National Cancer Center Japan, New Delhi and Council of Scientific and Industrial Research (CSIR), and among others.

Reasons to Buy:
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the oligonucleotide synthesis market.

  • Highlights key business priorities in order to assist companies to realign their business strategies.

  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific oligonucleotide synthesis market, thereby allowing players across the value chain to develop effective long-term strategies.

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents

1. Introduction
1.1 Scope Of The Study
1.2 Research Report Guidance
2. Asia Pacific Oligonucleotide Synthesis Market - Key Takeaways
3. Asia Pacific Oligonucleotide Synthesis Market - Market Landscape
3.1 Overview
3.1.1 Asia Pacific Oligonucleotide Synthesis Market - By Product
3.1.2 Asia Pacific Oligonucleotide Synthesis Market - By Application
3.1.3 Asia Pacific Oligonucleotide Synthesis Market - By End User
3.1.4 Asia Pacific Oligonucleotide Synthesis Market - By Country
3.2 PEST Analysis
4. Asia Pacific Oligonucleotide Synthesis Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Growing Use Of Synthesized Oligonucleotides
4.1.2 Government Support For Biotechnology Research
4.2 Key Market Restraints
4.2.1 Dearth of Skilled Professional
4.3 Key Market Opportunities
4.3.1 Extensive Use of Oligonucleotide for Medical Applications
4.4 Future Trends
4.4.1 Advancements in Synthetic Biology
4.5 Impact Analysis
5. Oligonucleotide Synthesis Market - Asia Pacific Analysis
5.1 Asia Pacific Oligonucleotide Synthesis Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.2.1 Thermo Fisher Scientific Inc.
5.2.2 GenScript
6. Asia Pacific Oligonucleotide Synthesis Market Analysis - By Product
6.1 Overview
6.2 Asia Pacific Oligonucleotide Synthesis Market By Product, 2018 & 2027 (%)
6.3 Asia Pacific Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (Us$ Mn)
6.4 Primers Market
6.4.1 Overview
6.4.2 Primers Market Revenue and Forecast to 2027 (US$ Mn)
6.5 Probes Market
6.5.1 Overview
6.5.2 Probes Market Revenue and Forecast to 2027 (US$ Mn)
6.6 Large-Scale Synthesis Oligonucleotides Market
6.6.1 Overview
6.6.2 Large-Scale Synthesis Oligonucleotides Market Revenue and Forecast to 2027 (US$ Mn)
6.7 Others Market
6.7.1 Overview
6.7.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
6.8 Reagents Market
6.8.1 Overview
6.8.2 APAC Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
6.9 Equipment Market
6.9.1 Overview
6.9.2 ASIA PACIFIC Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
7. Asia Pacific Oligonucleotide Synthesis Market Analysis - By Application
7.1 Overview
7.2 Asia Pacific Oligonucleotide Synthesis Market, By Application, 2018 & 2027 (%)
7.3 Asia Pacific Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (Us$ Mn)
7.4 Research Market
7.4.1 Overview
7.4.2 APAC Research Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Diagnostics Market
7.5.1 Overview
7.5.2 APAC Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Therapeutics Market
7.6.1 Overview
7.6.2 APAC Therapeutics Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
8. Asia Pacific Oligonucleotide Synthesis Market Analysis - By End User
8.1 Overview
8.2 Asia Pacific Oligonucleotide Synthesis Market, By End User, 2018 & 2027 (%)
8.3 Asia Pacific Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (Us$ Mn)
8.4 Academic Research Institutes Market
8.4.1 Overview
8.4.2 Asia Pacific Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Diagnostic Laboratories Market
8.5.1 Overview
8.5.2 Asia Pacific Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Pharmaceutical & Biotechnology Companies Market
8.6.1 Overview
8.6.2 Asia Pacific Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Other End Users Market
8.7.1 Overview
8.7.2 Asia Pacific Other End Users Market Revenue and Forecasts to 2027 (US$ Mn)
9. Asia Pacific Oligonucleotide Synthesis Market Revenue And Forecasts To 2027
9.1 Overview
9.1.1 Asia Pacific Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.2 Asia Pacific Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.2.1 Asia Pacific Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.3 Asia Pacific Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.4 Asia Pacific Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.5 Asia Pacific Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)
9.1.6 China Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.1 China Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.2 China Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.6.2.1 China Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.6.3 China Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.6.4 China Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.7 India Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.1 India Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.2 India Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.7.2.1 India Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.7.3 India Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.7.4 India Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.8 Japan Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.1 Japan Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.2 Japan Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.8.2.1 Japan Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.8.3 Japan Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.8.4 Japan Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.9 Australia Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9.1 Australia Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9.2 Australia Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.9.2.1 Australia Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.3 Australia Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.9.4 Australia Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.10 South Korea Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.10.1 South Korea Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.10.2 South Korea Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.10.2.1 South Korea Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.10.3 South Korea Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.10.4 South Korea Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10. Oligonucleotide Synthesis Market - Industry Landscape
10.1 Overview
10.2 Overview
10.3 Comparative Company Analysis
10.4 Growth Strategies done by the companies in the Market, (%)
10.5 Organic Developments
10.5.1 Overview
10.6 Inorganic developments
10.6.1 Overview
11. oligonucleotide synthesis Market-Key company profiles
11.1 Synthomics, Inc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Ansa Biotechnologies, Inc.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Iridia, Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Helixworks
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Keasling Lab
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Molecular Assemblies
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Overview
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Twist Bioscience
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Evonetix
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 DNA Script
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Nuclera Nucleics Ltd.
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
11.11 Camena Bio
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Financial Overview
11.11.4 Product Portfolio
11.11.5 SWOT Analysis
11.11.6 Key Developments
12. Appendix
12.1 About the Publisher
12.2 Glossary of Terms
12.3 Methodology
12.3.1 Coverage
12.3.2 Secondary Research
12.3.3 Primary Research

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Molecular Assemblies
  • Twist Bioscience
  • Evonetix
  • Nuclera Nucleics Ltd
  • Camena Bio
  • DNA Script
  • Iridia, Inc.,
  • Helixworks
  • Ansa Biotechnologies, Inc.,
  • Synthomics, Inc.,